Genmab A (GMAB) Other Working Capital Changes (2020 - 2026)

Genmab A (GMAB) has reported Other Working Capital Changes for 5 consecutive years, with -$3.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Other Working Capital Changes changed N/A year-over-year to -$3.0 million; the trailing twelve-month figure through Jun 2026 stood at $409.0 million (down 89.17% YoY), and the FY2023 full-year result was $128.0 million, up 174.52% from the prior year.
• Other Working Capital Changes grew to -$3.0 million in Q2 2026 per GMAB's latest filing, from -$7.0 million in the prior quarter.
• Across five years, Other Working Capital Changes topped out at $2.9 billion in Q1 2023 and bottomed at -$7.0 million in Q1 2026.
• Historically, Other Working Capital Changes has averaged $816.5 million across 3 years, with a median of $208.0 million in 2024.
• The widest YoY moves for Other Working Capital Changes: up 85.33% in 2024, down 85.33% in 2024.
• Over 3 years, Other Working Capital Changes stood at $2.9 billion in 2023, then sank by 85.33% to $419.0 million in 2024, then plunged by 100.72% to -$3.0 million in 2026.
• According to Business Quant data, Other Working Capital Changes over the past three periods registered -$3.0 million, -$7.0 million, and $419.0 million for Q2 2026, Q1 2026, and Q1 2024 respectively.